Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Neurotech International ( (AU:NTI) ) is now available.
Neurotech International has notified the market that 51,000,000 options, exercisable at $0.16 and due to expire on 24 April 2026, have lapsed without being exercised or converted. The cessation of these options slightly simplifies the company’s capital structure and removes a potential source of future share dilution, which may be relevant for existing shareholders assessing the company’s issued capital profile.
The notification, lodged as an Appendix 3H, confirms the formal removal of these options from Neurotech International’s listed securities. While the announcement does not detail operational changes, it clarifies the company’s current equity overhang and may influence how investors evaluate its future capital-raising flexibility and ownership dynamics.
More about Neurotech International
Neurotech International Limited is an Australian-listed company on the ASX under the code NTI. The specific industry and core products or services are not described in the announcement, but the company is subject to standard Australian capital markets and securities reporting requirements.
Average Trading Volume: 1,456,144
Technical Sentiment Signal: Sell
Current Market Cap: A$17.13M
For an in-depth examination of NTI stock, go to TipRanks’ Overview page.